

Choosing a contract packaging partner is more than finding who’s available. The right partner must understand your device, control the manufacturing process, support validation activities, and maintain the documentation required to move from design transfer to production.
Before selecting a packaging partner, medical device manufacturers should look closely at the facility, quality system, production model, and validation support.
With the help of Alec Respecki, Packaging Engineer II, we’ve established the five questions to ask before moving forward.
1. Do you have experience packaging devices similar to ours?
Medical devices vary widely in size, materials, configuration, sterilization requirements, and packaging needs. A facility that is well suited for one product may not have the equipment, environment, or process controls required for another.
Start by sharing a complete set of device and packaging requirements. This information helps the contract packager determine whether its existing facility and processes can support the project.
It is also important to discuss the activities that occur before sealing and final packaging. The device may requires specialized assembly and cleaning for example.
Experience with a similar device does not eliminate the need for careful planning. It does, however, give the potential partner a better understanding of the risks, documentation, and process controls that may be involved.
2. How do you demonstrate regulatory compliance and maintain quality?
It’s important to confirm that the contract packager maintains the appropriate FDA establishment registration and device listings for the activities it performs. You should also review whether the facility is certified to ISO 13485, the internationally recognized quality management system standard for medical devices.
The goal is to understand how the quality system works in practice and how your product will be controlled within it.
3. What are your volume requirements and anticipated lead times?
A capable contract manufacturer may still be the wrong operational fit if its minimum order quantities, lot charges, or production schedule do not align with your needs.
For early-stage companies, minimum runs can be particularly important. Some quantities may fall below a supplier’s normal production threshold. Ask how smaller batches are priced and whether minimum lot charges apply.
Materials, sterilization capacity, and quality review can affect the final delivery date. Requesting a realistic timeline can identify these dependencies early, especially when the packaging schedule is tied to a clinical or commercial launch.
4. What validation activities are required before production launch?
Validation can become one of the most time-consuming parts of a contract packaging transfer if roles and responsibilities are not defined upfront.
This becomes especially important when multiple manufacturers or service providers are involved. Moving an activity to a different site, changing process equipment, or introducing different product-contact materials may affect the applicability of existing validation evidence. In some cases, additional qualification or validation work may be required.
5. What documents control manufacturing, and how are changes managed after design transfer?
A controlled set of manufacturing documents should guide the work from incoming material inspection through final release. These records should provide clear evidence of what was built, which materials were used, who performed the work, and whether the product met requirements.
Manufacturers should also have a formal change-control process. After design transfer, even a seemingly small update can affect training, validation, inventory, and regulatory documentation.
Key Takeaways
The best contract packaging partner is not simply the company that can package the device. It is the company that can help build a controlled, traceable, and scalable process around it.
Evaluating experience, quality systems, production expectations, validation support, and change control early can prevent delays in production. It also gives both teams a better understanding of the requirements to move from design transfer to formal production.